Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2025-12-24 @ 5:24 PM
Study NCT ID:
NCT04711850
Status:
TERMINATED
Last Update Posted:
2025-05-28
First Post:
2021-01-13
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
Sponsor:
Hansa Biopharma AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20-HMedIdes-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None